Using a publically available gene expression array dataset [GenBank:GDS806] [22] from NCBI Gene Expression Omnibus profiles [23] we were able to identify that breast cancer patients receiving endocrine therapy, who had recurrence, had significantly higher gene expression levels of CD68 (Figure 3B). This evidence concerns the gene CD68 and breast carcinoma.